|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morgan E, Soerjomataram I, Rumgay H,
Coleman HG, Thrift AP, Vignat J, Laversanne M, Ferlay J and Arnold
M: The global landscape of esophageal squamous cell carcinoma and
esophageal adenocarcinoma incidence and mortality in 2020 and
projections to 2040: New estimates from GLOBOCAN 2020.
Gastroenterology. 163:649–658.e642. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Y, Zhang Y, Peng L and Zhang L:
research progress on the predicting factors and coping strategies
for postoperative recurrence of esophageal cancer. Cells.
12:1142022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gharagozloo M, Gris KV, Mahvelati T,
Amrani A, Lukens JR and Gris D: NLR-dependent regulation of
inflammation in multiple sclerosis. Front Immunol. 8:20122017.
View Article : Google Scholar
|
|
5
|
Liu M, Liu K, Cheng D, Zheng B, Li S and
Mo Z: The regulatory role of NLRX1 in innate immunity and human
disease. Cytokine. 160:1560552022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Singh K, Poteryakhina A, Zheltukhin A,
Bhatelia K, Prajapati P, Sripada L, Tomar D and Singh R, Singh AK,
Chumakov PM and Singh R: NLRX1 acts as tumor suppressor by
regulating TNF-α induced apoptosis and metabolism in cancer cells.
Biochim Biophys Acta. 1853:1073–1086. 2015. View Article : Google Scholar
|
|
7
|
Singh K, Roy M, Prajapati P, Lipatova A,
Sripada L, Gohel D, Singh A, Mane M, Godbole MM, Chumakov PM and
Singh R: NLRX1 regulates TNF-α-induced mitochondria-lysosomal
crosstalk to maintain the invasive and metastatic potential of
breast cancer cells. Biochim Biophys Acta Mol Basis Dis.
1865:1460–1476. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luo X, Donnelly CR, Gong W, Heath BR, Hao
Y, Donnelly LA, Moghbeli T, Tan YS, Lin X, Bellile E, et al: HPV16
drives cancer immune escape via NLRX1-mediated degradation of
STING. J Clin Invest. 130:1635–1652. 2020. View Article : Google Scholar
|
|
9
|
Soares F, Tattoli I, Rahman MA, Robertson
SJ, Belcheva A, Liu D, Streutker C, Winer S, Winer DA, Martin A, et
al: The mitochondrial protein NLRX1 controls the balance between
extrinsic and intrinsic apoptosis. J Biol Chem. 289:19317–19330.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tattoli I, Killackey SA, Foerster EG,
Molinaro R, Maisonneuve C, Rahman MA, Winer S, Winer DA, Streutker
CJ, Philpott DJ and Girardin SE: NLRX1 acts as an
epithelial-intrinsic tumor suppressor through the modulation of
TNF-mediated proliferation. Cell Rep. 14:2576–2586. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Coutermarsh-Ott S, Simmons A, Capria V,
LeRoith T, Wilson JE, Heid B, Philipson CW, Qin Q,
Hontecillas-Magarzo R, Bassaganya-Riera J, et al: NLRX1 suppresses
tumorigenesis and attenuates histiocytic sarcoma through the
negative regulation of NF-κB signaling. Oncotarget. 7:33096–33110.
2016. View Article : Google Scholar
|
|
12
|
Koblansky AA, Truax AD, Liu R, Montgomery
SA, Ding S, Wilson JE, Brickey WJ, Mühlbauer M, McFadden RM, Hu P,
et al: The innate immune receptor NLRX1 functions as a tumor
suppressor by reducing colon tumorigenesis and key tumor-promoting
signals. Cell Rep. 14:2562–2575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu B, Ding GY, Fu PY, Zhu XD, Ji Y, Shi
GM, Shen YH, Cai JB, Yang Z, Zhou J, et al: NOD-like receptor X1
functions as a tumor suppressor by inhibiting
epithelial-mesenchymal transition and inducing aging in
hepatocellular carcinoma cells. J Hematol Oncol. 11:282018.
View Article : Google Scholar
|
|
14
|
Nagai-Singer MA, Morrison HA, Woolls MK,
Leedy K, Imran KM, Tupik JD and Allen IC: NLRX1 functions as a
tumor suppressor in Pan02 pancreatic cancer cells. Front Oncol.
13:11558312023. View Article : Google Scholar
|
|
15
|
Hu N, Clifford RJ, Yang HH, Wang C,
Goldstein AM, Ding T, Taylor PR and Lee MP: Genome wide analysis of
DNA copy number neutral loss of heterozygosity (CNNLOH) and its
relation to gene expression in esophageal squamous cell carcinoma.
BMC Genomics. 11:5762010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hyland PL, Zhang H, Yang Q, Yang HH, Hu N,
Lin SW, Su H, Wang L, Wang C, Ding T, et al: Pathway, in silico and
tissue-specific expression quantitative analyses of oesophageal
squamous cell carcinoma genome-wide association studies data. Int J
Epidemiol. 45:206–220. 2016. View Article : Google Scholar
|
|
17
|
Liu J, Wang Y, Chu Y, Xu R, Zhang D and
Wang X: Identification of a TLR-induced four-lncRNA signature as a
novel prognostic biomarker in esophageal carcinoma. Front Cell Dev
Biol. 8:6492020. View Article : Google Scholar
|
|
18
|
Hu N, Wang C, Zhang T, Su H, Liu H, Yang
HH, Giffen C, Hu Y, Taylor PR and Goldstein AM: CSMD1 shows complex
patterns of somatic copy number alterations and expressions of
mRNAs and target Micro RNAs in esophageal squamous cell carcinoma.
Cancers (Basel). 14:50012022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Team RCJMc, . R: A language and
environment for statistical computing. 12014
|
|
20
|
Sepulveda JL: Using R and bioconductor in
clinical genomics and transcriptomics. J Mol Diagn. 22:3–20. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hänzelmann S, Castelo R and Guinney J:
GSVA: Gene set variation analysis for microarray and RNA-seq data.
BMC Bioinformatics. 14:72013. View Article : Google Scholar
|
|
24
|
Zhou L, Gan L and Liu Z: Expression and
prognostic value of AIM1L in esophageal squamous cell carcinoma.
Medicine (Baltimore). 102:e346772023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
An J, Chen X, Chen W, Liang R, Reinach PS,
Yan D and Tu L: MicroRNA expression profile and the role of miR-204
in corneal wound healing. Invest Ophthalmol Vis Sci. 56:3673–3683.
2015. View Article : Google Scholar
|
|
26
|
Zou Y, Wu F, Liu Q, Deng X, Hai R, He X
and Zhou X: Downregulation of miRNA-328 promotes the angiogenesis
of HUVECs by regulating the PIM1 and AKT/mTOR signaling pathway
under high glucose and low serum condition. Mol Med Rep.
22:895–905. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang ZJ, Huang YP, Liu ZT, Wang YX, Zhou
H, Hou KX, Tang JW, Xiong L, Wen Y and Huang SF: Identification of
immune related gene signature for predicting prognosis of
cholangiocarcinoma patients. Front Immunol. 14:10284042023.
View Article : Google Scholar
|
|
28
|
Wang X, Yang C, Liao X, Han C, Yu T, Huang
K, Yu L, Qin W, Zhu G, Su H, et al: NLRC and NLRX gene family mRNA
expression and prognostic value in hepatocellular carcinoma. Cancer
Med. 6:2660–2672. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liang G, Wang H, Shi H, Zhu M, An J, Qi Y,
Du J, Li Y and Gao S: Porphyromonas gingivalis promotes the
proliferation and migration of esophageal squamous cell carcinoma
through the miR-194/GRHL3/PTEN/Akt axis. ACS Infect Dis. 6:871–881.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Georgy SR, Rudiatmoko DR, Auden A,
Partridge D, Butt T, Srivastava S, Wong N, Swaroop D, Carpinelli
MR, Yan F, et al: Identification of a novel
GRHL3/HOPX/Wnt/β-catenin proto-oncogenic axis in squamous cell
carcinoma of the esophagus. Cell Mol Gastroenterol Hepatol.
15:1051–1069. 2023. View Article : Google Scholar
|
|
31
|
Mellman I and Yarden Y: Endocytosis and
cancer. Cold Spring Harb Perspect Biol. 5:a0169492013. View Article : Google Scholar
|
|
32
|
Sonkar K, Ayyappan V, Tressler CM, Adelaja
O, Cai R, Cheng M and Glunde K: Focus on the glycerophosphocholine
pathway in choline phospholipid metabolism of cancer. NMR Biomed.
32:e41122019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fiorito V, Chiabrando D, Petrillo S,
Bertino F and Tolosano E: The multifaceted role of heme in cancer.
Front Oncol. 9:15402019. View Article : Google Scholar
|
|
34
|
Bian X, Liu R, Meng Y, Xing D, Xu D and Lu
Z: Lipid metabolism and cancer. J Exp Med. 218:e202016062021.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tjelle TE, Lovdal T and Berg T: Phagosome
dynamics and function. Bioessays. 22:255–263. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu SY, Fu T, Jiang YZ and Shao ZM: Natural
killer cells in cancer biology and therapy. Mol Cancer. 19:1202020.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Olingy CE, Dinh HQ and Hedrick CC:
Monocyte heterogeneity and functions in cancer. J Leukoc Biol.
106:309–322. 2019. View Article : Google Scholar
|
|
38
|
Ugel S, Canè S, De Sanctis F and Bronte V:
Monocytes in the tumor microenvironment. Annu Rev Pathol.
16:93–122. 2021. View Article : Google Scholar
|
|
39
|
Chaintreuil P, Kerreneur E, Bourgoin M,
Savy C, Favreau C, Robert G, Jacquel A and Auberger P: The
generation, activation, and polarization of monocyte-derived
macrophages in human malignancies. Front Immunol. 14:11783372023.
View Article : Google Scholar
|
|
40
|
Daigeler A, Chromik AM, Geisler A, Bulut
D, Hilgert C, Krieg A, Klein-Hitpass L, Lehnhardt M, Uhl W and
Mittelkötter U: Synergistic apoptotic effects of taurolidine and
TRAIL on squamous carcinoma cells of the esophagus. Int J Oncol.
32:1205–1220. 2008. View Article : Google Scholar
|
|
41
|
Bittner S and Ehrenschwender M:
Multifaceted death receptor 3 signaling-promoting survival and
triggering death. FEBS Lett. 591:2543–2555. 2017. View Article : Google Scholar
|
|
42
|
Wu J and Wang Y: Role of TNFSF9
bidirectional signal transduction in antitumor immunotherapy. Eur J
Pharmacol. 928:1750972022. View Article : Google Scholar
|
|
43
|
Fan Z, Pan J, Wang H and Zhang Y: NOD-like
receptor X1, tumor necrosis factor receptor-associated factor 6 and
NF-κB are associated with clinicopathological characteristics in
gastric cancer. Exp Ther Med. 21:2082021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Castaño-Rodríguez N, Kaakoush NO, Goh KL,
Fock KM and Mitchell HM: The NOD-like receptor signalling pathway
in Helicobacter pylori infection and related gastric cancer: A
case-control study and gene expression analyses. PLoS One.
9:e988992014. View Article : Google Scholar
|
